154 related articles for article (PubMed ID: 26756113)
21. Chromosome 11 allele loss in sporadic insulinoma.
Patel P; O'Rahilly S; Buckle V; Nakamura Y; Turner RC; Wainscoat JS
J Clin Pathol; 1990 May; 43(5):377-8. PubMed ID: 2164532
[TBL] [Abstract][Full Text] [Related]
22. Insulinoma in childhood: clinical, radiological, molecular and histological aspects of nine patients.
Padidela R; Fiest M; Arya V; Smith VV; Ashworth M; Rampling D; Newbould M; Batra G; James J; Wright NB; Dunne MJ; Clayton PE; Banerjee I; Hussain K
Eur J Endocrinol; 2014 May; 170(5):741-7. PubMed ID: 24599222
[TBL] [Abstract][Full Text] [Related]
23. Molecular alterations during insulinoma tumorigenesis.
Jonkers YM; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2007 Jun; 1775(2):313-32. PubMed ID: 17572302
[TBL] [Abstract][Full Text] [Related]
24. [The role and mechanism of high expression of cyclin B2 in MEN1 insulinoma].
Wu T; Huang XH
Sheng Li Xue Bao; 2011 Dec; 63(6):555-64. PubMed ID: 22193451
[TBL] [Abstract][Full Text] [Related]
25. Synchronous Solid Pseudopapillary Tumor and Insulinoma in an Adolescent MEN1 Patient Presenting with Diagnostic Dilemmas.
Uçar A; Özgüven B; Battal M; Alparslan Pınarlı F; Özmen E; Yetim A; Yılmaz Y
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):375-379. PubMed ID: 28663159
[TBL] [Abstract][Full Text] [Related]
26. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
Modali SD; Parekh VI; Kebebew E; Agarwal SK
Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
[TBL] [Abstract][Full Text] [Related]
28. [Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance].
Jiang WJ; Liu TH; Chen J; Gao J; Wu SF; Chen YJ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1705-9. PubMed ID: 15569430
[TBL] [Abstract][Full Text] [Related]
29. Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1.
Bartsch DK; Albers M; Knoop R; Kann PH; Fendrich V; Waldmann J
Neuroendocrinology; 2013; 98(4):290-8. PubMed ID: 24356648
[TBL] [Abstract][Full Text] [Related]
30. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.
Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N
Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646
[TBL] [Abstract][Full Text] [Related]
31. Of mice and MEN1: Insulinomas in a conditional mouse knockout.
Crabtree JS; Scacheri PC; Ward JM; McNally SR; Swain GP; Montagna C; Hager JH; Hanahan D; Edlund H; Magnuson MA; Garrett-Beal L; Burns AL; Ried T; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Mol Cell Biol; 2003 Sep; 23(17):6075-85. PubMed ID: 12917331
[TBL] [Abstract][Full Text] [Related]
32. High frequency of down-regulation of E-cadherin detected in benign sporadic insulinomas by multiplex ligation-dependent probe amplification.
Jia H; Jiang X; Zhao Z; Ge Y; Lu J; Zhao Y; Cui B; Ning G
Hum Pathol; 2009 Sep; 40(9):1336-41. PubMed ID: 19427668
[TBL] [Abstract][Full Text] [Related]
33. Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas.
Lichtenauer UD; Di Dalmazi G; Slater EP; Wieland T; Kuebart A; Schmittfull A; Schwarzmayr T; Diener S; Wiese D; Thasler WE; Reincke M; Meitinger T; Schott M; Fassnacht M; Bartsch DK; Strom TM; Beuschlein F
J Clin Endocrinol Metab; 2015 May; 100(5):E776-82. PubMed ID: 25763608
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopic management of insulinoma in a child with multiple endocrine neoplasia type 1.
de Vogelaere K; De Schepper J; Vanhoeij M; De Mey J; Goossens A; Vanbesien J; De Backer A; Delvaux G
J Laparoendosc Adv Surg Tech A; 2006 Jun; 16(3):335-8. PubMed ID: 16796455
[TBL] [Abstract][Full Text] [Related]
35. Aneuploidy in pancreatic insulinomas does not predict malignancy.
Graeme-Cook F; Bell DA; Flotte TJ; Preffer F; Pastel-Levy C; Nardi G; Compton C
Cancer; 1990 Dec; 66(11):2365-8. PubMed ID: 2245392
[TBL] [Abstract][Full Text] [Related]
36. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas.
Speel EJ; Scheidweiler AF; Zhao J; Matter C; Saremaslani P; Roth J; Heitz PU; Komminoth P
Cancer Res; 2001 Jul; 61(13):5186-92. PubMed ID: 11431358
[TBL] [Abstract][Full Text] [Related]
37. Survey of genetic alterations in gastrinomas.
Yu F; Jensen RT; Lubensky IA; Mahlamaki EH; Zheng YL; Herr AM; Ferrin LJ
Cancer Res; 2000 Oct; 60(19):5536-42. PubMed ID: 11034099
[TBL] [Abstract][Full Text] [Related]
38. Aggressive versus indolent insulinomas: new clinicopathological insights.
Hackeng WM; Brosens LAA; Dreijerink KMA
Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36779771
[TBL] [Abstract][Full Text] [Related]
39. Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases.
Tham E; Grandell U; Lindgren E; Toss G; Skogseid B; Nordenskjöld M
J Clin Endocrinol Metab; 2007 Sep; 92(9):3389-95. PubMed ID: 17623761
[TBL] [Abstract][Full Text] [Related]
40. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
